Pestalozzi advises Helix Acquisition Corp (HLXA), a Nasdaq-listed SPAC, in its business combination with MoonLake Immunotherapeutics AG
\n\n\n \n \n \n
\n\n \n \n
\n \n \n \n 05.04.2022\n
\n \n Pestalozzi advises Helix Acquisition Corp (HLXA), a Nasdaq-listed SPAC, in its business combination with MoonLake Immunotherapeutics AG
\n\n \n En savoir plus\n \n \n
\n